AKT1 and cancer: PI3K/Akt/mTOR signaling pathway is therefore one of the major alternate pathways through which upstream regulators such as CD147 modulate HIF-1α expression and function resulting in adaptive angiogenesis and metabolic reprogramming exhibited by cancers (65, 70, 71).